CAS No 21732-98-9 |
1H-1,2,4-Triazole-5-carboxylicacid, hydrazidenull |
Inquiry |
CAS No 20440-93-1 |
Tris(4-nitrophenyl)aminenull |
Inquiry |
CAS No 209995-38-0 |
2,4,5-TRIFLUOROPHENYL ACETIC ACIDnull |
Inquiry |
CAS No 199291-95-7 |
1H-1,2,4-Triazole-3-carboxylicacid, 5-(acetylamino)-null |
Inquiry |
CAS No 1622-55-5 |
4-oxo-9,10-dihydro-4h-benzo(4,5)cyclohepto(1,2.b)thiophenenull |
Inquiry |
CAS No 162204-20-8 |
5`-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2`,3`-diacetatenull |
Inquiry |
CAS No 161798-01-2 |
Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylatenull |
Inquiry |
CAS No 161798-03-4 |
ETHYL 2-(3-FORMYL-4-ISOBUTOXYPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLATEnull |
Inquiry |
CAS No 161797-99-5 |
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylatenull |
Inquiry |
CAS No 160844-75-7 |
Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylatenull |
Inquiry |
CAS No 161599-46-8 |
2',3'-DI-O-ACETYL-5'-DEOXY-5-FLUOROCYTIDINEnull |
Inquiry |
CAS No 154361-50-9 |
Capecitabinenull |
Inquiry |
CAS No 152460-10-1 |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineaminenull |
Inquiry |
CAS No 147769-93-5 |
(S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]-BUTYLAMINEnull |
Inquiry |
CAS No 147526-32-7 |
Pitavastatin calciumnull |
Inquiry |
CAS No 1455-77-2 |
3,5-Diamino-1,2,4-triazolenull |
Inquiry |
CAS No 144060-53-7 |
Febuxostatnull |
Inquiry |
CAS No 142782-22-7 |
1H-1,2,4-Triazole-3-carboxylicacid, 5-amino-, methyl ester, hydrochloride (1:1)null |
Inquiry |
CAS No 136901-10-5; 27048-04-0 |
2-Amino-3-Nitro-6-Chloropyridinenull |
Inquiry |
CAS No 14002-51-8 |
4-Biphenylcarbonyl chloridenull |
Inquiry |
CAS No 135062-02-1 |
Repaglinidenull |
Inquiry |
CAS No 124752-23-4 |
(4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-Acetic acid,1,1-dimethylethyl esternull |
Inquiry |
CAS No 131052-49-8 |
1H-1,2,4-Triazole-5-methanamine,3-methyl-null |
Inquiry |
CAS No 123318-82-1 |
Clofarabinenull |
Inquiry |
CAS No 122111-01-7 |
2-Deoxy-2,2-difluoro-D-erythro-pentofuranous-1-ulose-3,5-dibenzoatenull |
Inquiry |